Systemic Bevacizumab (Avastin) for Juvenile‐Onset Recurrent Respiratory Papillomatosis: A Systematic Review-Reference-Cited by-同舟云学术

Systemic Bevacizumab (Avastin) for Juvenile‐Onset Recurrent Respiratory Papillomatosis: A Systematic Review

Published:2020-09-22 Issue:5 Volume:131 Page:1138-1146
ISSN:0023-852X
Container-title:The Laryngoscope
language:en
Short-container-title:The Laryngoscope

Author:

Ryan Marisa A.¹^ORCID,Leu Grace R.²,Upchurch Patrick A.³⁴,Tunkel David E.¹,Walsh Jonathan M.¹,Boss Emily F.¹

Affiliation:

1. Department of Otolaryngology–Head and Neck Surgery Johns Hopkins University Baltimore Maryland U.S.A.

2. Tufts University School of Medicine Boston Massachusetts U.S.A.

3. Department of Anesthesiology and Critical Care Medicine Johns Hopkins University Baltimore Maryland U.S.A.

4. Department of Surgery Boston Children's Hospital Boston Massachusetts U.S.A.

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lary.29084

Reference41 articles.

1. RRP Foundation Patient Data Analysis. RRP patient stats. Available at:http://www.rrpf.org/patientstats.html. Accessed January 11 2019.

2. The natural history of human papillomavirus infections of the mucosal epithelia

3. Recurrent respiratory papillomatosis with lung and chest wall involvement: a rare complication in an adolescent;Rodriguez H;Acta Otorrinolaringol Esp,2018

4. Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis

5. Systemic bevacizumab for recurrent respiratory papillomatosis: A national survey

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Consensus Statement on the Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory Papillomatosis;The Laryngoscope;2024-08-03

2. Healthcare Spending and Systemic Bevacizumab for Recurrent Respiratory Papillomatosis;Journal of Voice;2024-04

3. Angiogenesis Inhibitor Drug-induced Benign Migratory Glossitis in a Patient of Juvenile-onset Recurrent Respiratory Papillomatosis under Maintenance Therapy;International Journal of Clinical Pediatric Dentistry;2024-03-14

4. Interim Results of a Phase 1/2 Open‐Label Study of INO‐3107 for HPV‐6 and/or HPV‐11‐Associated Recurrent Respiratory Papillomatosis;The Laryngoscope;2023-05-19

5. Systemic bevacizumab for recurrent respiratory papillomatosis. A case series;Acta Oto-Laryngologica Case Reports;2023-04-19